Quick Answer
Aldeyra Therapeutics, Inc. reported Shares Outstanding of 60.16 million shares for fiscal year 2025.
Aldeyra Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 60.16M | +0.9% |
| 2024 | 59.65M | +0.8% |
| 2023 | 59.20M | +1.1% |
| 2022 | 58.56M | +0.8% |
| 2021 | 58.08M | +50.2% |
| 2020 | 38.67M | +34.9% |
| 2019 | 28.66M | +9.2% |
| 2018 | 26.24M | +37.1% |
| 2017 | 19.14M | +52.2% |
| 2016 | 12.58M | +29.5% |
| 2015 | 9.71M | +74.5% |
| 2014 | 5.57M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 60.16M | +1.0% | +0.2% |
| June 30, 2025 | 60.05M | +1.1% | +0.0% |
| March 31, 2025 | 60.05M | +1.1% | +0.7% |
| December 31, 2024 | 59.65M | +0.8% | +0.2% |
| September 30, 2024 | 59.55M | +0.6% | +0.2% |
| June 30, 2024 | 59.41M | +1.0% | +0.0% |
| March 31, 2024 | 59.41M | +1.1% | +0.4% |
| December 31, 2023 | 59.20M | +1.1% | +0.0% |
- Aldeyra Therapeutics, Inc. showed an increase of +0.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2025 period, Aldeyra Therapeutics, Inc.’s shares outstanding has grown by 981.0% (from 5.57 million shares to 60.16 million shares).
- The most recent figure is from Aldeyra Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: